Abstract
Depression is common in older individuals and is associated with high disability and increased mortality, yet the factors predicting late-life depression (LLD) are poorly understood. The relationship between of depressive disorder, age- and disease-related processes have generated pathogenic hypotheses and provided new treatment options. LLD syndrome is often related to a variety of vascular mechanisms, in particular hypertension, cerebral small vessel disease, white matter lesions, subcortical vascular impairment, and other processes (e.g., inflammation, neuroimmune regulatory dysmechanisms, neurodegenerative changes, amyloid accumulation) that may represent etiological factors by affecting frontolimbic and other neuronal networks predisposing to depression. The "vascular depression" hypothesis suggests that cerebrovascular disease (CVD) and vascular risk factors may predispose, induce or perpetuate geriatric depressive disorders. It is based on the presence of various cerebrovascular risk factors in many patients with LLD, its co-morbidity with cerebrovascular lesions, and the frequent development of depression after stroke. Other findings related to vascular depression are atrophy of the medial temporal cortex or generalized cortical atrophy that are usually associated with cognitive impairment. Other pathogenetic hypotheses of LLD, such as metabolic or inflammatory ones, are briefly discussed. Treatment planning should consider there may be a modest response to antidepressants, but several evidence-based and novel treatment options for LLD exist, such as electroconvulsive therapy, transcranial magnetic stimulation, neurobiology-based psychotherapy, as well as antihypertension and antiinflammatory drugs. However, their effectiveness needs further investigation, and new methodologies for prevention and treatment of depression in older individuals should be developed.
Similar content being viewed by others
Abbreviations
- AD:
-
Alzheimer disease
- BBB:
-
Blood–brain barrier
- CBF:
-
Cerebral blood flow
- CSVD:
-
Cerebral small vessel disease
- CVD:
-
Cerebrovascular disease
- ECT:
-
Electroconvulsive therapy
- LLD:
-
Late-life depression
- LOD:
-
Late-onset depression
- MCI:
-
Mild cognitive impairment
- MDD:
-
Major depressive disorders
- VaD:
-
Vascular depression
- VRFs:
-
Vascular risk factors
- WMH:
-
White matter hyperintensities
- WML:
-
White matter lesions
References
Abi Zeid Daou M, Boyd BD, Donahue MJ, Albert K, Taylor WD (2018) Anterior-posterior gradient differences in lobar and cingulate cortex cerebral blood flow in late-life depression. J Psychiatr Res 97:1–7
Abi-Jaoudé JG, Naiem AA, Edwards T, Lukaszewski MA, Obrand DI, Steinmetz OK, Bayne JP, MacKenzie KS, Gill HL, Girsowicz E (2022) Comorbid depression is associated with increased major adverse limb events in peripheral arterial disease: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg. https://doi.org/10.1016/j.ejvs.2022.04.020
Aizenstein HJ, Baskys A, Boldrini M, Butters MA, Diniz BS, Jaiswal MK, Jellinger KA, Kruglov LS, Meshandin IA, Mijajlovic MD, Niklewski G, Pospos S, Raju K, Richter K, Steffens DC, Taylor WD, Tene O (2016) Vascular depression consensus report - a critical update. BMC Med 14:161
Alexopoulos GS (2001) “The depression-executive dysfunction syndrome of late life”: a specific target for D3 agonists? Am J Geriatr Psychiatry 9:22–29
Alexopoulos GS (2005) Depression in the elderly. Lancet 365:1961–1970
Alexopoulos GS (2019) Mechanisms and treatment of late-life depression. Transl Psychiatry 9:188
Alexopoulos GS, Arean P (2014) A model for streamlining psychotherapy in the RDoC era: the example of “Engage.” Mol Psychiatry 19:14–19
Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M (1997) “Vascular depression” hypothesis. Arch Gen Psychiatry 54:915–922
Alghamdi BS (2018) The neuroprotective role of melatonin in neurological disorders. J Neurosci Res 96:1136–1149
Almdahl IS, Agartz I, Hugdahl K, Korsnes MS (2022) Brain pathology and cognitive scores prior to onset of late-life depression. Int J Geriatr Psychiatry 37:1–15
Almeida OP, Hankey GJ, Yeap BB, Golledge J, Norman PE, Flicker L (2015) Depression, frailty, and all-cause mortality: a cohort study of men older than 75 years. J Am Med Dir Assoc 16:296–300
Andreescu C, Ajilore O, Aizenstein HJ, Albert K, Butters MA, Landman BA, Karim HT, Krafty R, Taylor WD (2019) Disruption of neural homeostasis as a model of relapse and recurrence in late-life depression. Am J Geriatr Psychiatry 27:1316–1330
Bae KY, Kang HJ, Kim JW, Kim SW, Kim JT, Park MS, Cho KH, Kim JM (2019) Associations of white matter hyperintensities with poststroke depression: A 1-year longitudinal study. Int J Geriatr Psychiatry 34:162–168
Banerjee G, Jang H, Kim HJ, Kim ST, Kim JS, Lee JH, Im K, Kwon H, Lee JM, Na DL, Seo SW, Werring DJ (2018) Total MRI small vessel disease burden correlates with cognitive performance, cortical atrophy, and network measures in a memory clinic population. J Alzheimer’s Dis 36:1485–1497
Beekman AT (2011) Neuropathological correlates of late-life depression. Expert Rev Neurother 11:947–949
Bezerra DM, Pereira FR, Cendes F, Jackowski MP, Nakano EY, Moscoso MA, Ribeiz SR, Avila R, Castro CC, Bottino CM (2012) DTI voxelwise analysis did not differentiate older depressed patients from older subjects without depression. J Psychiatr Res 46:1643–1649
Blöchl M, Schaare HL, Kunzmann U, Nestler S (2022) The age-dependent association between vascular risk factors and depressed mood. J Gerontol B Psychol Sci Soc Sci 77:284–294
Bogoian HR, Dotson VM (2022) Vascular depression in Black Americans: A systematic review of the construct and its cognitive, functional, and psychosocial correlates. Clin Neuropsychol 36:431–461
Boldrini M, Santiago AN, Hen R, Dwork AJ, Rosoklija GB, Tamir H, Arango V, John Mann J (2013) Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression. Neuropsychopharmacology 38:1068–1077
Brookes RL, Herbert V, Lawrence AJ, Morris RG, Markus HS (2014) Depression in small-vessel disease relates to white matter ultrastructural damage, not disability. Neurology 83:1417–1423
Brunoni AR, Bensenor IM, Alves TC (2011) Therapeutic interventions for vascular depression: a systematic review. Rev Bras Psiquiatr 33:400–409
Byun MS, Choe YM, Sohn BK, Yi D, Han JY, Park J, Choi HJ, Baek H, Lee JH, Kim HJ, Kim YK, Yoon EJ, Sohn CH, Woo JI, Lee DY (2016) Association of cerebral amyloidosis, blood pressure, and neuronal injury with late-life onset depression. Front Aging Neurosci 8:236
Castello JP, Pasi M, Kubiszewski P, Abramson JR, Charidimou A, Kourkoulis C, DiPucchio Z, Schwab K, Anderson CD, Gurol ME, Greenberg SM, Rosand J, Viswanathan A, Biffi A (2022) Cerebral small vessel disease and depression among intracerebral hemorrhage survivors. Stroke 53:523–531
Chachamovich E, Fleck M, Laidlaw K, Power M (2008) Impact of major depression and subsyndromal symptoms on quality of life and attitudes toward aging in an international sample of older adults. Gerontologist 48:593–602
Chithiramohan T, Parekh JN, Kronenberg G, Haunton VJ, Minhas JS, Panerai RB, Robinson TG, Divall P, Subramaniam H, Mukaetova-Ladinska E, Beishon L (2022) Investigating the association between depression and cerebral haemodynamics-A systematic review and meta-analysis. J Affect Disord 299:144–158
Choi KS, Holtzheimer PE, Franco AR, Kelley ME, Dunlop BW, Hu XP, Mayberg HS (2014) Reconciling variable findings of white matter integrity in major depressive disorder. Neuropsychopharmacology 39:1332–1339
Comijs HC, Nieuwesteeg J, Kok R, van Marwijk HW, van der Mast RC, Naarding P, Voshaar RC, Verhaak P, de Waal MW, Stek ML (2015) The two-year course of late-life depression; results from the Netherlands study of depression in older persons. BMC Psychiatry 15:20
Cooper C, Katona C, Lyketsos K, Blazer D, Brodaty H, Rabins P, de MendonAsa Lima CA, Livingston G (2011) A systematic review of treatments for refractory depression in older people. Am J Psychiatry 168:681–688
Culang-Reinlieb ME, Johnert LC, Brickman AM, Steffens DC, Garcon E, Sneed JR (2011) MRI-defined vascular depression: a review of the construct. Int J Geriatr Psychiatry 26:1101–1108
Dafsari FS, Bewernick B, Biewer M, Christ H, Domschke K, Froelich L, Hellmich M, Luppa M, Peters O, Ramirez A, Riedel-Heller S, Schramm E, Vry MS, Wagner M, Hautzinger M, Jessen F (2019) Cognitive behavioural therapy for the treatment of late life depression: study protocol of a multicentre, randomized, observer-blinded, controlled trial (CBTlate). BMC Psychiatry 19:423
Dalby RB, Eskildsen SF, Videbech P, Rosenberg R, Østergaard L (2021) Cerebral hemodynamics and capillary dysfunction in late-onset major depressive disorder. Psychiatry Res Neuroimaging 317:111383
de Bekker A, Geerlings MI, Uitewaal-Poslawsky IE, de Man-van Ginkel JM (2022) Depression in stroke survivors: ten-year follow-up. Determinants of the natural course of depressive symptoms in stroke survivors in the Netherlands: the SMART-Medea study. J Stroke Cerebrovasc Dis 31:106272
De Ryck A, Fransen E, Brouns R, Geurden M, Peij D, Mariën P, De Deyn PP, Engelborghs S, (2014) Poststroke depression and its multifactorial nature: results from a prospective longitudinal study. J Neurol Sci 347:159–166
Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF 3rd (2013) Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry 202:329–335
Diniz BS, Sibille E, Ding Y, Tseng G, Aizenstein HJ, Lotrich F, Becker JT, Lopez OL, Lotze MT, Klunk WE, Reynolds CF, Butters MA (2015) Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression. Mol Psychiatry 20:594–601
Dion-Albert L, Cadoret A, Doney E, Kaufmann FN, Dudek KA, Daigle B, Parise LF, Cathomas F, Samba N, Hudson N, Lebel M, Campbell M, Turecki G, Mechawar N, Menard C (2022) Vascular and blood-brain barrier-related changes underlie stress responses and resilience in female mice and depression in human tissue. Nat Commun 13:164
Disabato BM, Sheline YI (2012) Biological basis of late life depression. Curr Psychiatry Rep 14:273–279
Djernes JK (2006) Prevalence and predictors of depression in populations of elderly: a review. Acta Psychiatr Scand 113:372–387
Dombrovski AY, Szanto K, Clark L, Aizenstein HJ, Chase HW, Reynolds CF 3rd, Siegle GJ (2015) Corticostriatothalamic reward prediction error signals and executive control in late-life depression. Psychol Med 45:1413–1424
Dubin MJ, Liston C, Avissar MA, Ilieva I, Gunning FM (2017) Network-guided transcranial magnetic stimulation for depression. Curr Behav Neurosci Rep 4:70–77
Dudek KA, Dion-Albert L, Lebel M, LeClair K, Labrecque S, Tuck E, Ferrer Perez C, Golden SA, Tamminga C, Turecki G, Mechawar N, Russo SJ, Menard C (2020) Molecular adaptations of the blood-brain barrier promote stress resilience vs. depression. Proc Natl Acad Sci U S A 117:3326–3336
Dudek KA, Dion-Albert L, Kaufmann FN, Tuck E, Lebel M, Menard C (2021) Neurobiology of resilience in depression: immune and vascular insights from human and animal studies. Eur J Neurosci 53:183–221
Egglefield DA, Schiff S, Motter JN, Grinberg A, Rutherford BR, Sneed JR (2021) Cortical thickness and hippocampal volume in vascular and non-vascular depressed patients. Front Psychiatry 12:697489
Empana JP, Boutouyrie P, Lemogne C, Jouven X, van Sloten TT (2021) Microvascular contribution to late-onset depression: mechanisms, current evidence, association with other brain diseases, and therapeutic perspectives. Biol Psychiatry 90:214–225
Fan RR, Rudnick SB, Minami HR, Chen AM, Zemela MS, Wittgen CM, Williams MS, Smeds MR (2022) Depression screening in patients with vascular disease. Vascular. https://doi.org/10.1177/17085381221084817
Fang Y, Qin T, Liu W, Ran L, Yang Y, Huang H, Pan D, Wang M (2020) Cerebral small-vessel disease and risk of incidence of depression: a meta-analysis of longitudinal cohort studies. J Am Heart Assoc 9:e016512
Firbank MJ, Teodorczuk A, van der Flier WM, Gouw AA, Wallin A, Erkinjuntti T, Inzitari D, Wahlund LO, Pantoni L, Poggesi A, Pracucci G, Langhorne P, O’Brien JT (2012) Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study. Br J Psychiatry 201:40–45
Fulton S, Décarie-Spain L, Fioramonti X, Guiard B, Nakajima S (2022) The menace of obesity to depression and anxiety prevalence. Trends Endocrinol Metab 33:18–35
Gandelman JA, Albert K, Boyd BD, Park JW, Riddle M, Woodward ND, Kang H, Landman BA, Taylor WD (2019) Intrinsic functional network connectivity is associated with clinical symptoms and cognition in late-life depression. Biol Psychiatry Cogn Neurosci Neuroimaging 4:160–170
Gatchel JR, Rabin JS, Buckley RF, Locascio JJ, Quiroz YT, Yang HS, Vannini P, Amariglio RE, Rentz DM, Properzi M, Donovan NJ, Blacker D, Johnson KA, Sperling RA, Marshall GA (2019) Longitudinal association of depression symptoms with cognition and cortical amyloid among community-dwelling older adults. JAMA Netw Open 2:e198964
Geraets AFJ, Schram MT, Jansen JFA, Koster A, Dagnelie PC, van Greevenbroek MMJ, Stehouwer CDA, Verhey FRJ, Köhler S (2021) The relation of depression with structural brain abnormalities and cognitive functioning: the Maastricht study. Psychol Med. https://doi.org/10.1017/S0033291721000222
Geraets AFJ, Köhler S, Schram MT (2022) Vascular and metabolic risk factors of late-life depression. Vessel plus 6:19. https://doi.org/10.20517/22574-21209.22021.20102
Gerritsen L, Sigurdsson S, Jonsson PV, Gudnason V, Launer LJ, Geerlings MI (2022a) Depressive symptom profiles predict dementia onset and brain pathology in older persons. The AGES-Reykjavik study. Neurobiol Aging 111:14–23
Gerritsen L, Twait EL, Jonsson PV, Gudnason V, Launer LJ, Geerlings MI (2022b) Depression and dementia: the role of cortisol and vascular brain lesions. AGES-Reykjavik study. J Alzheimers Dis 85:1677–1687
Godin O, Dufouil C, Maillard P, Delcroix N, Mazoyer B, Crivello F, Alperovitch A, Tzourio C (2008) White matter lesions as a predictor of depression in the elderly: the 3C-Dijon study. Biol Psychiatry 63:663–669
Gonzalez HM, Tarraf W, Whitfield K, Gallo JJ (2012) Vascular depression prevalence and epidemiology in the United States. J Psychiatr Res 46:456–461
Grool AM, van der Graaf Y, Mali WP, Geerlings MI (2011) Location of cerebrovascular and degenerative changes, depressive symptoms and cognitive functioning in later life: the SMART-Medea study. J Neurol Neurosurg Psychiatry 82:1093–1100
Gudmundsson P, Olesen PJ, Simoni M, Pantoni L, Ostling S, Kern S, Guo X, Skoog I (2015) White matter lesions and temporal lobe atrophy related to incidence of both dementia and major depression in 70-year-olds followed over 10 years. Eur J Neurol 22(781–788):e749-750
Gunning FM, Oberlin LE, Schier M, Victoria LW (2021) Brain-based mechanisms of late-life depression: Implications for novel interventions. Semin Cell Dev Biol 116:169–179
Guo J, Wang J, Sun W, Liu X (2022) The advances of post-stroke depression: 2021 update. J Neurol 269:1236–1249
Hashem AH, M N, Gomaa MA, Khalaf OO, (2017) Late versus early onset depression in elderly patients: vascular risk and cognitive impairment. Curr Aging Sci 10:211–216
Hayley S, Hakim AM, Albert PR (2021) Depression, dementia and immune dysregulation. Brain 144:746–760
Hryhorczuk C, Sharma S, Fulton SE (2013) Metabolic disturbances connecting obesity and depression. Front Neurosci 7:177
Ismail Z, Malick A, Smith EE, Schweizer T, Fischer C (2014) Depression versus dementia: is this construct still relevant? Neurodegener Dis Manag 4:119–126
Ismail Z, Elbayoumi H, Fischer CE, Hogan DB, Millikin CP, Schweizer T, Mortby ME, Smith EE, Patten SB, Fiest KM (2017) Prevalence of depression in patients with mild cognitive impairment: a systematic review and meta-analysis. JAMA Psychiat 74:58–67
Jamieson A, Goodwill AM, Termine M, Campbell S, Szoeke C (2019) Depression related cerebral pathology and its relationship with cognitive functioning: A systematic review. J Affect Disord 250:410–418
Jang YJ, Kang C, Myung W, Lim SW, Moon YK, Kim H, Kim DK (2021) Additive interaction of mid- to late-life depression and cerebrovascular disease on the risk of dementia: a nationwide population-based cohort study. Alzheimers Res Ther 13:61
Jellinger KA (2013) Organic bases of late-life depression: a critical update. J Neural Transm 120:1109–1125
Jellinger KA (2021) Pathomechanisms of vascular depression in older adults. Int J Mol Sci 23:308
Jokinen H, Melkas S, Madureira S, Verdelho A, Ferro JM, Fazekas F, Schmidt R, Scheltens P, Barkhof F, Wardlaw JM, Inzitari D, Pantoni L, Erkinjuntti T (2016) Cognitive reserve moderates long-term cognitive and functional outcome in cerebral small vessel disease. J Neurol Neurosurg Psychiatry 87:1296–1302
Jorge RE, Moser DJ, Acion L, Robinson RG (2008) Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry 65:268–276
Jurek L, Dorey JM, Nourredine M, Galvao F, Brunelin J (2021) Impact of vascular risk factors on clinical outcome in elderly patients with depression receiving electroconvulsive therapy. J Affect Disord 279:308–315
Kalkman HO (2020) The association between vascular inflammation and depressive disorder causality, biomarkers and targeted treatment. Pharmaceuticals (Basel) 13:92
Kaster TS, Daskalakis ZJ, Noda Y, Knyahnytska Y, Downar J, Rajji TK, Levkovitz Y, Zangen A, Butters MA, Mulsant BH, Blumberger DM (2018) Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trial. Neuropsychopharmacology 43:2231–2238
Kellner CH, Husain MM, Knapp RG, McCall WV, Petrides G, Rudorfer MV, Young RC, Sampson S, McClintock SM, Mueller M, Prudic J, Greenberg RM, Weiner RD, Bailine SH, Rosenquist PB, Raza A, Kaliora S, Latoussakis V, Tobias KG, Briggs MC, Liebman LS, Geduldig ET, Teklehaimanot AA, Lisanby SH (2016) Right unilateral ultrabrief pulse ECT in geriatric depression: Phase 1 of the PRIDE study. Am J Psychiatry 173:1101–1109
Kim YK, Han KM (2021) Neural substrates for late-life depression: A selective review of structural neuroimaging studies. Prog Neuropsychopharmacol Biol Psychiatry 104:110010
Kim S, Woo SY, Kang HS, Lim SW, Choi SH, Myung W, Jeong JH, Lee Y, Hong CH, Kim JH, Na H, Carroll BJ, Kim DK (2015) Factors related to prevalence, persistence, and incidence of depressive symptoms in mild cognitive impairment: vascular depression construct. Int J Geriatr Psychiatry 31:818–826
Kim Y, Jang H, Kim SJ, Cho SH, Kim SE, Kim ST, Kim HJ, Moon SH, Ewers M, Im K, Kwon H, Na DL, Seo SW (2018) Vascular effects on depressive symptoms in cognitive impairment. J Alzheimers Dis 65:597–605
Kiosses DN, Alexopoulos GS (2013) The prognostic significance of subsyndromal symptoms emerging after remission of late-life depression. Psychol Med 43:341–350
Koenig AM, DeLozier IJ, Zmuda MD, Marron MM, Begley AE, Anderson SJ, Reynolds CF 3rd, Arnold SE, Becker JT, Butters MA (2015) Neuropsychological functioning in the acute and remitted States of late-life depression. J Alzheimers Dis 45:175–185
Köhler S, Thomas AJ, Barnett NA, O’Brien JT (2010) The pattern and course of cognitive impairment in late-life depression. Psychol Med 40:591–602
Krishnan KR, Hays JC, Blazer DG (1997) MRI-defined vascular depression. Am J Psychiatry 154:497–501
Krishnan KR, Taylor WD, McQuoid DR, MacFall JR, Payne ME, Provenzale JM, Steffens DC (2004) Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol Psychiatry 55:390–397
Krishnan MS, O’Brien JT, Firbank MJ, Pantoni L, Carlucci G, Erkinjuntti T, Wallin A, Wahlund LO, Scheltens P, van Straaten EC, Inzitari D (2006) Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS Study. Int J Geriatr Psychiatry 21:983–989
Kuo CY, Lin CH, Lane HY (2021) Molecular basis of late-life depression. Int J Mol Sci 22:7421
Laborde-Lahoz P, El-Gabalawy R, Kinley J, Kirwin PD, Sareen J, Pietrzak RH (2015) Subsyndromal depression among older adults in the USA: prevalence, comorbidity, and risk for new-onset psychiatric disorders in late life. Int J Geriatr Psychiatry 30:677–685
Lan Y, Pan C, Qiu X, Miao J, Sun W, Li G, Zhao X, Zhu Z, Zhu S (2022) Nomogram for persistent post-stroke depression and decision curve analysis. Clin Interv Aging 17:393–403
Lee EH, Kim JW, Kang HJ, Kim SW, Shin IS, Kim JT, Park MS, Cho KH, Kim JM (2021) Effects of acute and chronic depression on 12-year long-term outcomes after stroke. Int J Geriatr Psychiatry 36:1759–1766
Lenze EJ, Mulsant BH, Blumberger DM, Karp JF, Newcomer JW, Anderson SJ, Dew MA, Butters MA, Stack JA, Begley AE, Reynolds CF 3rd (2015) Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial. Lancet 386:2404–2412
Leung DKY, Chan WC, Spector A, Wong GHY (2021) Prevalence of depression, anxiety, and apathy symptoms across dementia stages: A systematic review and meta-analysis. Int J Geriatr Psychiatry 36:1330–1344
Liguori C, Pierantozzi M, Chiaravalloti A, Sancesario GM, Mercuri NB, Franchini F, Schillaci O, Sancesario G (2018) When cognitive decline and depression coexist in the elderly: CSF biomarkers analysis can differentiate Alzheimer’s disease from late-life depression. Front Aging Neurosci 10:38
Lin C, Huang CM, Fan YT, Liu HL, Chen YL, Aizenstein HJ, Lee TM, Lee SH (2020) Cognitive reserve moderates effects of white matter hyperintensity on depressive symptoms and cognitive function in late-life depression. Front Psychiatry 11:249
Linnemann C, Lang UE (2020) Pathways connecting late-life depression and dementia. Front Pharmacol 11:279
Long Y, Yang TT, Sun ZW (2012) Vascular risk factors and cognitive impairment of patients with magnetic resonance imaging-defined subcortical ischemic depression. Zhonghua Yi Xue Za Zhi 92:307–311
Loureiro JC, Stella F, Pais MV, Radanovic M, Canineu PR, Joaquim HPG, Talib LL, Forlenza OV (2020) Cognitive impairment in remitted late-life depression is not associated with Alzheimer’s disease-related CSF biomarkers. J Affect Disord 272:409–416
Mahgoub N, Alexopoulos GS (2016) Amyloid hypothesis: is there a role for antiamyloid treatment in late-life depression? Am J Geriatr Psychiatry 24:239–247
Marshe VS, Maciukiewicz M, Hauschild AC, Islam F, Qin L, Tiwari AK, Sibille E, Blumberger DM, Karp JF, Flint AJ, Turecki G, Lam RW, Milev RV, Frey BN, Rotzinger S, Foster JA, Kennedy SH, Kennedy JL, Mulsant BH, Reynolds CF 3rd, Lenze EJ, Müller DJ (2021) Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response. Transl Psychiatry 11:127
Martín-Peláez S, Serra-Majem L, Cano-Ibáñez N, Martínez-González MÁ, Salas-Salvadó J, Corella D, Lassale C, Martínez J, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones F, Lapetra J, Fernández-Aranda F, Bueno-Cavanillas A, Tur J, Martín V, Pintó X, Delgado-Rodríguez M, Matía P, Vidal J, Vázquez C, Daimiel L, Ros E, Toledo E, Nishi S, Sorli J, Malcampo M, Zulet M, Moreno-Rodríguez A, Cueto-Galán R, Vivancos-Aparicio D, Colom A, García-Ríos A, Casas R, Bernal-López MR, Santos-Lozano JM, Vázquez Z, Gómez-Martínez C, Ortega-Azorín C, Del V, Abete I, Goikoetxea-Bahon A, Pascual E, Becerra-Tomás N, Chillarón JJ, Sánchez-Villegas A (2022) Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study. PLoS One 17:e0265079
Massardo T, Quintana JC, Jaimovich R, Sáez CG, Risco L, Liberman C, Araya AV, Galleguillos T, Castro-Mora G, Pereira J (2021) Regional brain perfusion is associated with endothelial dysfunction markers in major depressive disorder. Neuropsychobiology 80:214–224
Matsushima J, Kawashima T, Nabeta H, Imamura Y, Watanabe I, Mizoguchi Y, Kojima N, Yamada S, Monji A (2015) Association of inflammatory biomarkers with depressive symptoms and cognitive decline in a community-dwelling healthy older sample: a 3-year follow-up study. J Affect Disord 173:9–14
Mayneris-Perxachs J, Castells-Nobau A, Arnoriaga-Rodríguez M, Martin M, de la Vega-Correa L, Zapata C, Burokas A, Blasco G, Coll C, Escrichs A, Biarnés C, Moreno-Navarrete JM, Puig J, Garre-Olmo J, Ramos R, Pedraza S, Brugada R, Vilanova JC, Serena J, Gich J, Ramió-Torrentà L, Pérez-Brocal V, Moya A, Pamplona R, Sol J, Jové M, Ricart W, Portero-Otin M, Deco G, Maldonado R, Fernández-Real JM (2022) Microbiota alterations in proline metabolism impact depression. Cell Metab 34(5):681–701.e10. https://doi.org/10.1016/j.cmet.2022.04.001
McCutcheon ST, Han D, Troncoso J, Koliatsos VE, Albert M, Lyketsos CG, Leoutsakos JS (2016) Clinicopathological correlates of depression in early Alzheimer’s disease in the NACC. Int J Geriatr Psychiatry 31:1301–1311
Medina A, Watson SJ, Bunney W Jr, Myers RM, Schatzberg A, Barchas J, Akil H, Thompson RC (2016) Evidence for alterations of the glial syncytial function in major depressive disorder. J Psychiatr Res 72:15–21
Moon B, Kim S, Park YH, Lim JS, Youn YC, Jang JW (2017) Depressive symptoms are associated with progression to dementia in patients with amyloid-positive mild cognitive impairment. J Alzheimers Dis 58:1255–1264
Morimoto SS, Alexopoulos GS (2013) Cognitive deficits in geriatric depression: clinical correlates and implications for current and future treatment. Psychiatr Clin North Am 36:517–531
Morimoto SS, Gunning FM, Wexler BE, Hu W, Ilieva I, Liu J, Nitis J, Alexopoulos GS (2016) Executive dysfunction predicts treatment response to neuroplasticity-based computerized cognitive remediation (nCCR-GD) in elderly patients with major depression. Am J Geriatr Psychiatry 24:816–820
Motter JN, Lee S, Sneed JR, Doraiswamy PM, Pelton GH, Petrella JR, Devanand DP (2021) Cortical thickness predicts remission of depression with antidepressants in patients with late-life depression and cognitive impairment. J Affect Disord 295:438–445
Naarding P, Tiemeier H, Breteler MM, Schoevers RA, Jonker C, Koudstaal PJ, Beekman AT (2007) Clinically defined vascular depression in the general population. Psychol Med 37:383–392
Naismith SL, Norrie LM, Mowszowski L, Hickie IB (2012) The neurobiology of depression in later-life: clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol 98:99–143
Nie J, Fang Y, Chen Y, Aidina A, Qiu Q, Zhao L, Liu X, Sun L, Li Y, Zhong C, Li X (2022) Characteristics of dysregulated proinflammatory cytokines and cognitive dysfunction in late-life depression and amnestic mild cognitive impairment. Front Immunol 12:803633
Nunes PV, Suemoto CK, Rodriguez RD, Leite REP, Nascimento C, Pasqualucci CA, Nitrini R, Jacob-Filho W, Grinberg LT, Lafer B (2022) Neuropathology of depression in non-demented older adults: a large postmortem study of 741 individuals. Neurobiol Aging. https://doi.org/10.1016/j.neurobiolaging.2022.05.007
Oberlin LE, Respino M, Victoria L, Abreu L, Hoptman MJ, Alexopoulos GS, Gunning FM (2021) Late-life depression accentuates cognitive weaknesses in older adults with small vessel disease. Neuropsychopharmacology. https://doi.org/10.1038/s41386-021-00973-z
Oberlin LE, Respino M, Victoria L, Abreu L, Hoptman MJ, Alexopoulos GS, Gunning FM (2022) Late-life depression accentuates cognitive weaknesses in older adults with small vessel disease. Neuropsychopharmacology 47:580–587
Olazarán J, García-Polo P, García-Frank D, Quirós A, Hernández-Tamames J, Acedo C, Álvarez-Linera J, Frank A (2016) Structural correlates of depressive symptoms in prodromal Alzheimer’s disease. J Adv Med Medic Res 14:1–10. https://doi.org/10.9734/BJMMR/2016/24034
Oudega ML, Siddiqui A, Wattjes MP, Barkhof F, Kate MT, Muller M, Bouckaert F, Vandenbulcke M, De Winter FL, Sienaert P, Stek ML, Comijs HC, Korten NCM, Emsell L, Eikelenboom P, Rhebergen D, van Exel E, Dols A (2021) Are apathy and depressive symptoms related to vascular white matter hyperintensities in severe late life depression? J Geriatr Psychiatry Neurol 34:21–28
Özel F, Hilal S, de Feijter M, van der Velpen I, Direk N, Ikram MA, Vernooij MW, Luik AI (2022) Associations of neuroimaging markers with depressive symptoms over time in middle-aged and elderly persons. Psychol Med. https://doi.org/10.1017/S003329172200112X
Paradise MB, Naismith SL, Norrie LM, Graeber MB, Hickie IB (2012) The role of glia in late-life depression. Int Psychogeriatr 24:1878–1890
Park JH, Lee SB, Lee TJ, Lee DY, Jhoo JH, Youn JC, Choo IH, Choi EA, Jeong JW, Choe JY, Woo JI, Kim KW (2007) Depression in vascular dementia is quantitatively and qualitatively different from depression in Alzheimer’s disease. Dement Geriatr Cogn Disord 23:67–73
Park JH, Lee SB, Lee JJ, Yoon JC, Han JW, Kim TH, Jeong HG, Newhouse PA, Taylor WD, Kim JH, Woo JI, Kim KW (2015) Epidemiology of MRI-defined vascular depression: A longitudinal, community-based study in Korean elders. J Affect Disord 180:200–206
Parsaik AK, Singh B, Murad MH, Singh K, Mascarenhas SS, Williams MD, Lapid MI, Richardson JW, West CP, Rummans TA (2014) Statins use and risk of depression: a systematic review and meta-analysis. J Affect Disord 160:62–67
Paulson D, Lichtenberg PA (2013) Vascular depression and frailty: a compound threat to longevity among older-old women. Aging Ment Health 17:901–910
Penninx BW, Geerlings SW, Deeg DJ, van Eijk JT, van Tilburg W, Beekman AT (1999) Minor and major depression and the risk of death in older persons. Arch Gen Psychiatry 56:889–895
Pericaud A, Straczek C, Montastruc F, Leboyer M, Yrondi A, Arbus C (2022) Use of antidepressants in unipolar depression in the elderly [French]. Encephale
Perna L, Trares K, Perneczky R, Tato M, Stocker H, Möllers T, Holleczek B, Schöttker B, Brenner H (2021) RICHTIG: 2022 –- Risk of late-onset depression and cognitive decline: Results from inflammatory proteome analyses in a prospective population-based cohort study. Am J Geriatr Psychiatry 30:689–700
Pimontel MA, Reinlieb ME, Johnert LC, Garcon E, Sneed JR, Roose SP (2013) The external validity of MRI-defined vascular depression. Int J Geriatr Psychiatry 28:1189–1196
Piras F, Banaj N, Porcari DE, Spalletta G (2021) Later life depression as risk factor for developing dementia: epidemiological evidence, predictive models, preventive strategies and future trends. Minerva Med 112:456–466
Potter GG, McQuoid DR, Steffens DC, Welsh-Bohmer KA, Krishnan KR (2009) Neuropsychological correlates of magnetic resonance imaging-defined subcortical ischemic depression. Int J Geriatr Psychiatry 24:219–225
Prins ND, Scheltens P (2015) White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol 11:157–165
Puglisi V, Bramanti A, Lanza G, Cantone M, Vinciguerra L, Pennisi M, Bonanno L, Pennisi G, Bella R (2018) Impaired cerebral haemodynamics in vascular depression: insights from transcranial doppler ultrasonography. Front Psychiatry 9:316
Qiu WQ, Himali JJ, Wolf PA, DeCarli DC, Beiser A, Au R (2017) Effects of white matter integrity and brain volumes on late life depression in the Framingham Heart Study. Int J Geriatr Psychiatry 32:214–221
Rabat Y, Houeze R, Sagnier S, Olindo S, Poli M, Debruxelles S, Renou P, Rouanet F, Berthoz S, Sibon I (2021) Association between neurological outcome and poststroke comorbid mood and anxiety disorders: A real-life experience. Brain Behav 11:e02158
Rainer MK, Mucke HA, Zehetmayer S, Krampla W, Kuselbauer T, Weissgram S, Jungwirth S, Tragl KH, Fischer P (2006) Data from the VITA study do not support the concept of vascular depression. Am J Geriatr Psychiatry 14:531–537
Raison CL (2017) The promise and limitations of anti-inflammatory agents for the treatment of major depressive disorder. Curr Top Behav Neurosci 31:287–302
Rastogi A, Weissert R, Bhaskar SMM (2022) Leukoaraiosis severity and post-reperfusion outcomes in acute ischaemic stroke: A meta-analysis. Acta Neurol Scand 145:171–184
Rensma SP, van Sloten TT, Launer LJ, Stehouwer CDA (2018) Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality: A systematic review and meta-analysis. Neurosci Biobehav Rev 90:164–173
Respino M, Jaywant A, Kuceyeski A, Victoria LW, Hoptman MJ, Scult MA, Sankin L, Pimontel M, Liston C, Belvederi Murri M, Alexopoulos GS, Gunning FM (2019) The impact of white matter hyperintensities on the structural connectome in late-life depression: Relationship to executive functions. Neuroimage Clin 23:101852
Reynolds CF 3rd, Butters MA, Lopez O, Pollock BG, Dew MA, Mulsant BH, Lenze EJ, Holm M, Rogers JC, Mazumdar S, Houck PR, Begley A, Anderson S, Karp JF, Miller MD, Whyte EM, Stack J, Gildengers A, Szanto K, Bensasi S, Kaufer DI, Kamboh MI, DeKosky ST (2011) Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Arch Gen Psychiatry 68:51–60
Ribeiro NF, Madruga L (2021) A sudden and severe depressive episode after a left cingulate gyrus stroke: a case report of post-stroke depression and review of literature. J Neural Transm (vienna) 128:711–716
Rushia SN, Shehab AAS, Motter JN, Egglefield DA, Schiff S, Sneed JR, Garcon E (2020) Vascular depression for radiology: A review of the construct, methodology, and diagnosis. World J Radiol 12:48–67
Saadi A, Okeng’o K, Biseko MR, Shayo AF, Mmbando TN, Grundy SJ, Xu A, Parker RA, Wibecan L, Iyer G, Onesmo PM, Kapina BN, Regenhardt RW, Mateen FJ (2018) Post-stroke social networks, depressive symptoms, and disability in Tanzania: A prospective study. Int J Stroke 13:840–848
Sáiz-Vázquez O, Gracia-García P, Ubillos-Landa S, Puente-Martínez A, Casado-Yusta S, Olaya B, Santabárbara J (2021) Depression as a risk factor for Alzheimer’s disease: a systematic review of longitudinal meta-analyses. J Clin Med 10:1809
Salo KI, Scharfen J, Wilden ID, Schubotz RI, Holling H (2019) Confining the concept of vascular depression to late-onset depression: a meta-analysis of MRI-defined hyperintensity burden in major depressive disorder and bipolar disorder. Front Psychol 10:1241
Santos M, Kovari E, Hof PR, Gold G, Bouras C, Giannakopoulos P (2009) The impact of vascular burden on late-life depression. Brain Res Rev 62:19–32
Santos M, Gold G, Kovari E, Herrmann FR, Hof PR, Bouras C, Giannakopoulos P (2010) Neuropathological analysis of lacunes and microvascular lesions in late-onset depression. Neuropathol Appl Neurobiol 36:661–672
Schaakxs R, Comijs HC, Lamers F, Kok RM, Beekman ATF, Penninx B (2018) Associations between age and the course of major depressive disorder: a 2-year longitudinal cohort study. Lancet Psychiatry 5:581–590
Sekhon S, Patel J, Sapra A (2021) Late Onset Depression. In: StatPearls [Internet], 2021/09/18 Edition. StatPearls Publishing Treasure Island (FL), p https://www.ncbi.nlm.nih.gov/books/NBK551507/
Serafini G, Amore M, Rihmer Z (2015) Microstructural brain abnormalities, affective temperaments, and suicidal behavior in patients with major depression. Neuroimmunol Neuroinflammation 2:200–214
Sexton CE, Mackay CE, Ebmeier KP (2013) A systematic review and meta-analysis of magnetic resonance imaging studies in late-life depression. Am J Geriatr Psychiatry 21:184–195
Sheline YI, Pieper CF, Barch DM, Welsh-Bohmer K, McKinstry RC, MacFall JR, D’Angelo G, Garcia KS, Gersing K, Wilkins C, Taylor W, Steffens DC, Krishnan RR, Doraiswamy PM (2010) Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry 67:277–285
Shen X, Adams MJ, Ritakari TE, Cox SR, McIntosh AM, Whalley HC (2019) White matter microstructure and its relation to longitudinal measures of depressive symptoms in mid- and late life. Biol Psychiatry 86:759–768
Shin M, Sohn MK, Lee J, Kim DY, Shin YI, Oh GJ, Lee YS, Joo MC, Lee SY, Song MK, Han J, Ahn J, Lee YH, Chang WH, Shin S, Choi SM, Lee SK, Kim YH (2022) Post-stroke depression and cognitive aging: a multicenter, prospective cohort study. J Pers Med 12:389
Sible IJ, Jang JY, Sultzer DL, Nation DA (2022) Visit-to-visit blood pressure variability and subthreshold depressive symptoms in older adults. Am J Geriatr Psychiatry. https://doi.org/10.1016/j.jagp.2022.1003.1006
Spaans HP, Sienaert P, Bouckaert F, van den Berg JF, Verwijk E, Kho KH, Stek ML, Kok RM (2015) Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication. Br J Psychiatry 206:67–71
Spaans HP, Kok RM, Bouckaert F, Van Den Berg JF, Tunney OC, Sienaert P, Verwijk E, Kho KH, Stek ML (2018) Vascular risk factors in older patients with depression: outcome of electroconvulsive therapy versus medication. Int J Geriatr Psychiatry 33:371–378
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ, Jacobs RE, Doubal FN, Ramirez J, Black SE, Nedergaard M, Benveniste H, Dichgans M, Iadecola C, Love S, Bath PM, Markus HS, Salman RA, Allan SM, Quinn TJ, Kalaria RN, Werring DJ, Carare RO, Touyz RM, Williams SCR, Moskowitz MA, Katusic ZS, Lutz SE, Lazarov O, Minshall RD, Rehman J, Davis TP, Wellington CL, Yuan C, Lockhart SN, Hughes TM, Chen CLH, Sachdev P, O’Brien JT, Skoog I, Pantoni L, Gustafson DR, Biessels GJ, Wallin A, Smith EE, Mok V, Wong A, Passmore P, Barkof F, Muller M, Breteler MMB, Román GC, Hamel E, Seshadri S, Gottesman RF, van Buchem MA, Arvanitakis Z, Schneider JA, Drewes LR, Hachinski V, Finch CE, Toga AW, Wardlaw JM, Zlokovic BV, (2019) Vascular dysfunction-The disregarded partner of Alzheimer’s disease. Alzheimers Dement 15:158–167
Taler M, Miron O, Gil-Ad I, Weizman A (2013) Neuroprotective and procognitive effects of sertraline: in vitro and in vivo studies. Neurosci Lett 550:93–97
Taragano FE, Allegri R, Vicario A, Bagnatti P, Lyketsos CG (2001) A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of “vascular depression.” Int J Geriatr Psychiatry 16:254–260
Taragano FE, Bagnatti P, Allegri RF (2005) A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of “vascular depression.” Int Psychogeriatr 17:487–498
Taylor WD, Steffens DC, Krishnan KR (2006) Psychiatric disease in the twenty-first century: The case for subcortical ischemic depression. Biol Psychiatry 60:1299–1303
Taylor WD, Aizenstein HJ, Alexopoulos GS (2013a) The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry 18:963–974
Taylor WD, Zhao Z, Ashley-Koch A, Payne ME, Steffens DC, Krishnan RR, Hauser E, MacFall JR (2013b) Fiber tract-specific white matter lesion severity Findings in late-life depression and by AGTR1 A1166C genotype. Hum Brain Mapp 34:295–303
Taylor WD, Schultz SK, Panaite V, Steffens DC (2018) Perspectives on the management of vascular depression. Am J Psychiatry 175:1169–1175
Taylor WD, Deng Y, Boyd BD, Donahue MJ, Albert K, McHugo M, Gandelman JA, Landman BA (2020) Medial temporal lobe volumes in late-life depression: effects of age and vascular risk factors. Brain Imaging Behav 14:19–29
Ter Telgte A, van Leijsen EMC, Wiegertjes K, Klijn CJM, Tuladhar AM, de Leeuw FE (2018) Cerebral small vessel disease: from a focal to a global perspective. Nat Rev Neurol 14:387–398
Thuile J, Even C, Guelfi JD (2007) Validity of vascular depression as a specific diagnostic: a review. Encephale 33:39–48
Tonhajzerova I, Sekaninova N, Bona Olexova L, Visnovcova Z (2020) Novel insight into neuroimmune regulatory mechanisms and biomarkers linking major depression and vascular diseases: the dilemma continues. Int J Mol Sci 21:2317
Tor PC, Bautovich A, Wang MJ, Martin D, Harvey SB, Loo C (2015) A systematic review and meta-analysis of brief versus ultrabrief right unilateral electroconvulsive therapy for depression. J Clin Psychiatry 76:e1092-1098
Torres-Platas SG, Nagy C, Wakid M, Turecki G, Mechawar N (2016) Glial fibrillary acidic protein is differentially expressed across cortical and subcortical regions in healthy brains and downregulated in the thalamus and caudate nucleus of depressed suicides. Mol Psychiatry 21:509–515
Troubat R, Barone P, Leman S, Desmidt T, Cressant A, Atanasova B, Brizard B, El Hage W, Surget A, Belzung C, Camus V (2021) Neuroinflammation and depression: A review. Eur J Neurosci 53:151–171
Tsopelas C, Stewart R, Savva GM, Brayne C, Ince P, Thomas A, Matthews FE (2011) Neuropathological correlates of late-life depression in older people. Br J Psychiatry 198:109–114
Valkanova V, Ebmeier KP (2013) Vascular risk factors and depression in later life: a systematic review and meta-analysis. Biol Psychiatry 73:406–413
van Agtmaal MJM, Houben A, Pouwer F, Stehouwer CDA, Schram MT (2017) Association of microvascular dysfunction with late-life depression: a systematic review and meta-analysis. JAMA Psychiat 74:729–739
van Sloten TT, Sigurdsson S, van Buchem MA, Phillips CL, Jonsson PV, Ding J, Schram MT, Harris TB, Gudnason V, Launer LJ (2015) Cerebral small vessel disease and association with higher incidence of depressive symptoms in a general elderly population: The AGES-Reykjavik study. Am J Psychiatry 172:570–578
Vogelzangs N, Beekman AT, van Reedt Dortland AK, Schoevers RA, Giltay EJ, de Jonge P, Penninx BW (2014) Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users. Neuropsychopharmacology 39:1624–1634
Vu NQ, Aizenstein HJ (2013) Depression in the elderly: brain correlates, neuropsychological findings, and role of vascular lesion load. Curr Opin Neurol 26:656–661
Vural EM, van Munster BC, de Rooij SE (2014) Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature. Drugs Aging 31:441–451
Wang R, Liu K, Ye X, Yan S (2018) Association between cerebral microbleeds and depression in the general elderly population: a meta-analysis. Front Psychiatry 9:94
Wang J, Lyu H, Chen J, Lin S, Zheng H, Li J, Kong F, Gao J, Yu H, Hu Y, Guo Z (2020) Cortical alterations are associated with depression in subcortical vascular mild cognitive impairment revealed by surface-based morphometry. J Alzheimers Dis 78:673–681
Wardlaw JM, Smith C, Dichgans M (2019) Small vessel disease: mechanisms and clinical implications. Lancet Neurol 18:684–696
Wei W, Karim HT, Lin C, Mizuno A, Andreescu C, Karp JF, Reynolds CF 3rd, Aizenstein HJ (2018) Trajectories in cerebral blood flow following antidepressant treatment in late-life depression: support for the vascular depression hypothesis. J Clin Psychiatry. https://doi.org/10.4088/JCP.18m12106
Wen MC, Steffens DC, Chen MK, Zainal NH (2014) Diffusion tensor imaging studies in late-life depression: systematic review and meta-analysis. Int J Geriatr Psychiatry 29:1173–1184
Wilson RS, Schneider JA, Bienias JL, Arnold SE, Evans DA, Bennett DA (2003) Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology 61:1102–1107
Wohleb ES, Franklin T, Iwata M, Duman RS (2016) Integrating neuroimmune systems in the neurobiology of depression. Nat Rev Neurosci 17:497–511
World Health Organization, ed (2017) Depression and Other Common Mental Disorders. Global Health Estimates. Geneva: World Health Organization - https://www.who.int/publications/i/item/depression-global-health-estimates
Wouts L, van Kessel M, Beekman ATF, Marijnissen RM, Oude Voshaar RC (2020) Empirical support for the vascular apathy hypothesis: A structured review. Int J Geriatr Psychiatry 35:3–11
Xekardaki A, Santos M, Hof P, Kövari E, Bouras C, Giannakopoulos G (2012) Neuropathological substrates and structural changes in late-life depression: the impact of vascular burden. Acta Neuropathol 124:453–464
Xie X, Shi Y, Zhang J (2017) Structural network connectivity impairment and depressive symptoms in cerebral small vessel disease. J Affect Disord 220:8–14
Xu Z, Wang J, Lyu H, Wang R, Hu Y, Guo Z, Xu J, Hu Q (2020) Alterations of white matter microstructure in subcortical vascular mild cognitive impairment with and without depressive symptoms. J Alzheimers Dis 73:1565–1573
Yasuno F, Kazui H, Morita N, Kajimoto K, Ihara M, Taguchi A, Yamamoto A, Matsuoka K, Kosaka J, Kudo T, Iida H, Kishimoto T, Nagatsuka K (2016) High amyloid-beta deposition related to depressive symptoms in older individuals with normal cognition: a pilot study. Int J Geriatr Psychiatry 31:920–928
Zanardi R, Poletti S, Prestifilippo D, Attanasio F, Barbini B, Colombo C (2020) Transcranial direct current stimulation: A novel approach in the treatment of vascular depression. Brain Stimul 13:1559–1565
Zhang Y, Li X, Chan VKY, Luo H, Chan SSM, Wong GHY, Wong ICK, Lum TYS (2022) Depression duration and risk of incident cardiovascular disease: A population-based six-year cohort study. J Affect Disord 305:188–195
Zivin K, Kales HC (2008) Adherence to depression treatment in older adults: a narrative review. Drugs Aging 25:559–571
Zuidersma M, Izaks GJ, Naarding P, Comijs HC, Oude Voshaar RC (2015) Vascular burden and cognitive function in late-life depression. Am J Geriatr Psychiatry 23:514–524
Acknowledgements
The author thanks Mr. E. Mitter-Ferstl, PhD, for secretarial and editorial work.
Funding
The study was funded by the Society for the Promotion of Research in Experimental Neurology, Vienna, Austria.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that he has no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jellinger, K.A. The enigma of vascular depression in old age: a critical update. J Neural Transm 129, 961–976 (2022). https://doi.org/10.1007/s00702-022-02521-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-022-02521-5